ASPET Discovery Health Professions

Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →